AU5397996A
(en )
1996-10-23
Iontophoretic transdermal system for the administration of at least two substances
IL117728A0
(en )
1996-07-23
Pharmaceutical compositions for transdermal administration
HUP9601566A2
(en )
1997-09-29
Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
AU4449789A
(en )
1990-05-31
Delivery system for pharmaceutical or therapeutic actives
EP0941039A4
(en )
2006-06-21
Transdermal administration of ment
HUP9900751A3
(en )
2000-07-28
Stable pharmaceutical forms of administration containing parathormone
GB2256588B8
(en )
Preparation for transdermal administration of procaterol
AU6934691A
(en )
1991-07-25
Transdermal administration of zwitterionic drugs
HUP0001263A3
(en )
2005-11-28
Methods of therapeutic administration of anti-cd4ol compounds
ZA968905B
(en )
1997-05-28
Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
IL116539A0
(en )
1996-03-31
Compositions for transdermal delivery of acid-labile drugs
HUP9801130A3
(en )
2001-03-28
Transdermal therapeutic system for administering testosterone
AU2559995A
(en )
1995-12-18
Transdermal delivery of anti-epileptic drugs
GB9601186D0
(en )
1996-03-20
Administration of Drugs
AU6821196A
(en )
1997-03-12
Transdermal administration of vorozole
IL117809A
(en )
2000-10-31
Medical patch for rate-controlled transdermal administration of risperidone
PT879054E
(en )
2008-03-05
Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse
SI0859595T1
(en )
2000-04-30
Therapeutic preparation for the transdermal administration of active substances
IL116615A
(en )
1999-09-22
Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts
GB9524942D0
(en )
1996-02-07
Drug therapy
AU1727397A
(en )
1997-08-28
Application of pyrrolidine derivatives to the preparation of medicaments for the treatment of drug abuse
DE29501910U1
(en )
1995-03-30
Transdermal therapeutic system containing the active ingredient dimethisoquine
GB9615710D0
(en )
1996-09-04
Pharmaceutical preparations for the treatment of sarcocystosis
DK0859595T3
(en )
2000-05-08
Therapeutic preparation for transdermal administration of active substances through the skin
SI0808158T1
(en )
2000-12-31
Medicament form for the delivery of active substances to wounds